Clinical Trials Logo

Hemodialysis Fistula Thrombosis clinical trials

View clinical trials related to Hemodialysis Fistula Thrombosis.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03289520 Completed - Kidney Failure Clinical Trials

Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis

FISTULA
Start date: January 7, 2003
Phase: Phase 3
Study type: Interventional

The objective of the study is to determine whether clopidogrel reduces the early failure rate of native AV fistulae. This study was originally registered as NCT00067119 which included two protocols, this one and the GRAFT study)

NCT ID: NCT02374762 Completed - Clinical trials for Chronic Kidney Disease

Hemodialysis Vascular Access Imaging Study

Start date: March 2015
Phase: N/A
Study type: Observational

The goal of this study is to find the best techniques to take non-invasive images of the arteriovenous fistula (AVF) in hemodialysis patients.

NCT ID: NCT00737620 Completed - Clinical trials for Hemodialysis Fistula Thrombosis

Evaluation of Heparin Bonded Vascular Graft Versus Standard Graft in Prosthetic Arteriovenous Access for Hemodialysis

Start date: March 2008
Phase: Phase 4
Study type: Interventional

The majority of bridge graft fistula with polytetrafluoroethylene (PTFE) for hemodialysis access will develop stenosis at the venous anastomosis and eventually will fail. Aspirin have been used for many years as a prophylactic drug therapy to prevent thrombosis but good clinical evidence for its benefit is lacking. Many drugs have been used to reduce intimal hyperplasia in animal models. Until recently there has been little success in clinical trials of anti-inflammatory, antiproliferative, antiplatelet, antithrombotic or calcium channel blocking drugs. Recently a major breakthrough was done by GORE when introducing the new heparin bonded PTFE graft by covalent attachment. This trial is planed to assess and compare between the GORE-TEX® PROPATEN vascular graft versus unmodified ePTFE grafts the patency and complication.